Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
The study found an 18% reduction in heart events (death, another heart attack, stroke, stenting or bypass, and hospitalization for heart pains) in the patients receiving chelation therapy
Study inclusion consisted of meta-analyses of randomized controlled trials (RCTs), with subjects aged 18 years or older, using L-carnitine as the intervention, with a control or placebo group, a duration of follow-up of 2 weeks, and outcomes including lipid profiles and changes in TG, HDL-C, LDL-C, and TC
- Prevent bone loss
Aberrant one-carbon metabolism processes have been associated with raised homocysteine levels as well as neural tube defects (NTDs), mood disorders and chronic diseases of lifestyle including certain cancers, and cardiovascular disease (CVD)
